The long lasting damage of the Women’s Health Initiative's hormone replacement study

Not SupportedThe original conclusions of the Women's Health Initiative regarding hormone replacement therapy have largely been overturned.

Not SupportedThe perceived risks of HRT for breast cancer are disproportionately feared compared to its benefits in reducing risk during perimenopause.

Partially SupportedThe Women's Health Initiative study showed that conjugated equine estrogen plus MPA increased breast cancer incidence by 0.1% in absolute risk but did not increase breast cancer mortality.